<?xml version="1.0" encoding="UTF-8"?>
<ref id="B219">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Villar</surname>
    <given-names>L. A.</given-names>
   </name>
   <name>
    <surname>Rivera-Medina</surname>
    <given-names>D. M.</given-names>
   </name>
   <name>
    <surname>Arredondo-Garcia</surname>
    <given-names>J. L.</given-names>
   </name>
   <name>
    <surname>Boaz</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Starr-Spires</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Thakur</surname>
    <given-names>M.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2013</year>). 
  <article-title>Safety and immunogenicity of a recombinant tetravalent dengue vaccine in 9-16 year olds: a randomized, controlled, phase II trial in Latin America</article-title>. 
  <source>Pediatr. Infect. Dis. J.</source>
  <volume>32</volume>, 
  <fpage>1102</fpage>â€“
  <lpage>1109</lpage>. 
  <pub-id pub-id-type="doi">10.1097/INF.0b013e31829b8022</pub-id>
  <?supplied-pmid 24067553?>
  <pub-id pub-id-type="pmid">24067553</pub-id>
 </mixed-citation>
</ref>
